|
|
|
|
| LEADER |
05607nam a22002775i 4500 |
| 001 |
000286174 |
| 005 |
20210512082040.0 |
| 007 |
cr nn 008mamaa |
| 008 |
140603s2014 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781461458364
|
| 024 |
7 |
|
|a 10.1007/978-1-4614-5836-4
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Handbook of Neurotoxicity /
|c edited by Richard M. Kostrzewa.
|
| 250 |
|
|
|a 1st ed. 2014.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2014.
|
| 300 |
|
|
|a 244 illus., 147 illus. in color. eReference. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Glutamate as a Neurotoxin,- Methamphetamine and MDMA neurotoxicity: Biochemical and molecular mechanisms -- Microglia: Neuroprotective and Neurodestructive Properties -- Neuroprotection in Demyelinating Diseases: the therapeutic potential of the neurotrophins -- Neurotrophic Factors and Ethanol Neurotoxicity -- Neurotrophic factors and NeuroAIDS: a lesson from brain-derived neurotrophic factor -- Neurotrophins and p75NTR in axonal regeneration and myelination -- Neurotrophins and pain -- Neurotrophin signalling in Cancer -- NGF and immune regulation -- NGF/P75 in cell cycle and tetraploidy -- P75 in neuronal death -- p75NTR processing and signaling: functional role -- p75NTR-A molecule with multiple functions in amyloid-beta metabolism and neurotoxicity -- RCSN Cell System for Identifying Dopaminergic Neurotoxicity -- Seizures tip the balance of neurotrophin signaling towards neuronal death -- Survey of Selective Neurotoxins -- Synthesis, trafficking and release of bdnf -- The Nature of DSP-4-Induced Neurotoxicity -- Trafficking of neurotrophins and their receptors and pathological significance -- TRPV1 activators ("vanilloids") as neurotoxins -- Experimental Approach to Alzheimer Disease -- Iron-induced dopaminergic cell death in vivo as a model of Parkinson´s disease -- Molecular, cellular and behavioural effects produced by perinatal asphyxia: protection by poly (ADP-ribose) polymerase 1 (PARP-1) inhibition -- MPTP: advances from an evergreen neurotoxin -- Multifunctional compounds for Parkinsons disease and Alzheimers disease -- Nanomedicines for Nervous System Diseases -- Neurodegenerative aspects of multiple system atrophy -- Neurotoxic profiles of designer-drugs -- Pathophysiology of obsessive-compulsive disorder: Insights from normal function and neurotoxic effects of drugs, infection and brain injury -- Physical Exercise as Intervention in Parkinsonism -- Protective agents in Parkinson´s disease: caffeine and adenosine A2A receptor antagonists -- Stem Cell Therapies for Age Associated Neurodegeneration -- AIDS -- Excitotoxicity and axon degeneration -- Glutamate Neurotoxicity related to Energy Failure -- Neuroprotection by Kynurenine Metabolites -- Pain -- Quinolinate and related excitotoxins: mechanisms of neurotoxicity and disease relevance -- Role of Ionotropic Glutamate Receptors in Neurodegenerative and Other Disorders -- Tardive Dyskinesia: Outcome of antipsychotic treatment and brain damage? -- The Concept of Excitotoxicity via Glu-R -- The pathogenesis of Alzheimers disease -- 5,6- and 5,7-Dihydroxytryptamines as Serotoninergic Neurotoxins -- Neurotoxicity of Methamphetamine -- Neurotoxic Effects, Mechanisms and Outcome of 192-IgG Saporin -- Neurotrophic therapy for ALS/ MND -- Cancer-mediated neurotoxicity -- Neurotoxicity in psychostimulant and opiate addiction -- Excitotoxicity in HIV associated neurocognitive disorders -- Necroptosis, a potential therapeutic target for neurological disorders -- Epilepsy -- Excitotoxicity and Amyotrophic Lateral Sclerosis -- Excitotoxicity in the Pathogenesis of Autism -- Glutamate Neurotoxicity, Transport and Alternate Splicing of Transporters -- Glutamatergic receptors in Parkinson`s disease -- Ionotropic Receptors in the Central Nervous System and Neurodegenerative Disease -- Lead & excitotoxicity -- Molecular Mechanism and Effects of Clostridial Neurotoxins -- MS & excitotoxicity -- Neuroprotectants Targeting NMDA Receptor Signaling -- Neurotoxicity and ALS: Insights into Pathogenesis -- Schizophrenia -- Neurotoxic Vulnerability Underlying Schizophrenia Spectrum Disorders -- Glutamate in the Pathogenesis of Gliomas -- Neurotoxicity and Neuroprotection in Spinal Cord Injury -- Drug Abuse Neurotoxicity: Alcohol and Nicotine as Developmental Stressors -- Botulinum neurotoxins as therapeutics -- MPTP Neurotoxicity: Actions, Mechanisms and Animal Modeling of Parkinsons disease -- Endogenous Kynurenic acid and Neurotoxicity -- The potential therapeutic effects of statins in Alzheimer's disease -- Drug Treatments for Alzheimer´s Disease: Hopes and Challenges -- Glutamate and Neurodegeneration in the Retina -- Stroke -- Brain trauma Neuroprotection -- Neuroprotective Strategies in Amyotrophic Lateral Sclerosis: Modulation of Neurotransmittory and Neurotrophic Input to Motor Neurons -- The role of Neurotoxicity in Depression -- Advances in stem cell research for Parkinson disease -- Neurotoxicity in Huntington Disease -- Fusion Models and ´Fusioning`in Parkinsonism: Protection and Restoration by Exercise -- Neurotoxicity: a complex multistage process involving different mechanisms.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
1 |
4 |
|a Neurosciences.
|
| 700 |
1 |
|
|a Kostrzewa, Richard M.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer Nature eReference
|
| 900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|